|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | AstraZeneca |
|---|---|
| Information provided by: | AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT00837967 |
Purpose
The primary objective of the study is to compare the tolerability of Symbicort Turbuhaler 160/4.5 μg 10 inhalations with terbutaline Turbuhaler 0.4 mg 10 inhalations for 3 days on top of Symbicort Turbuhaler 160/4.5 μg 1 inhalation bid in adult asthma patients.
| Condition | Intervention | Phase |
|---|---|---|
|
Asthma |
Drug: Symbicort Turbuhaler Drug: Terbutaline Turbuhaler |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Crossover Assignment, Pharmacodynamics Study |
| Official Title: | A Comparison of Tolerability of 10 Inhalations of Symbicort® Turbuhaler® 160/4.5 μg and 10 Inhalations of Terbutaline Turbuhaler 0.4 mg on Top of Symbicort Turbuhaler 160/4.5 μg 1 Inhalation Bid, Randomized, Double-blind, Cross Over, Phase III Study in Japanese Adults Asthma Patients |
| Enrollment: | 25 |
| Study Start Date: | January 2009 |
| Study Completion Date: | July 2009 |
| Arms | Assigned Interventions |
|---|---|
| 1: Experimental |
Drug: Symbicort Turbuhaler
160/4.5μg for 3 days
|
| 2: Active Comparator |
Drug: Terbutaline Turbuhaler
0.4 mg for 3 days
|
Eligibility| Ages Eligible for Study: | 16 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Responsible Party: | AstraZeneca Pharmaceuticals ( Tomas Andersson, MD, Medical Science Director Symbicort ) |
| Study ID Numbers: | D589LC00003 |
| Study First Received: | February 5, 2009 |
| Last Updated: | September 9, 2009 |
| ClinicalTrials.gov Identifier: | NCT00837967 History of Changes |
| Health Authority: | Japan: Ministry of Health, Labor and Welfare |
|
Asthma Symbicort Turbuhaler |
|
Anti-Inflammatory Agents Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Symbicort Bronchial Diseases Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Reproductive Control Agents Hormones Adrenergic Agonists Terbutaline Hypersensitivity Lung Diseases, Obstructive |
Respiratory Tract Diseases Tocolytic Agents Therapeutic Uses Immune System Diseases Adrenergic beta-Agonists Sympathomimetics Budesonide Asthma Anti-Asthmatic Agents Glucocorticoids Pharmacologic Actions Autonomic Agents Lung Diseases Hypersensitivity, Immediate Peripheral Nervous System Agents |